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Some things change, some stay the same
In his Comment to kick oﬀ  this month’s issue, 
Robert Casson invokes the “weeping” Greek philosopher 
Heraclitus to reﬂ ect on the changing nature of the world 
and the persistence of certain seemingly intractable 
issues—blindness, in Casson’s particular instance. In fact 
The Lancet Global Health this month contains many such 
examples of stubborn global problems, but also some 
instances of change: for the good, mostly, but which 
nevertheless necessitate careful consideration amid the 
political and social currents ﬂ owing around them.
To begin with the example of blindness, Rupert Bourne 
and colleagues’ Article presents a systematic analysis 
of the causes of global vision loss over the past two 
decades. Overall, the study shows that the number 
of people blind and vision-impaired in the world has 
not changed a great deal since 1990. This is because, 
although the numbers of people impaired by cataract 
and trachoma have decreased, the numbers blind and 
vision-impaired from glaucoma, macular degeneration, 
and uncorrected refractive error have increased. These 
increases, of course, are principally the consequence of 
an ageing world population, yet, according to Bourne 
and colleagues, 65% of current blindness and 76% of 
current moderate and severe vision impairment is still 
preventable or treatable. Striking disparities between 
world regions further highlight the considerable progress 
that still needs to be made for people living with these 
highly disabling impairments.
A further example of sluggish progress comes from the 
study by Belen Pedrique and colleagues. These authors 
update a systematic assessment of the drug and vaccine 
landscape for neglected diseases, last carried out in 2002. 
The previous assessment found that, between 1975 and 
1999, only 1·1% of new therapeutic products had been 
developed for diseases such as malaria, tuberculosis, 
diarrhoeal diseases, and neglected tropical diseases 
(as deﬁ ned by WHO). The new analysis found that the 
corresponding proportion for the years 2000–11 was 
4%. An improvement, yes, but one that reﬂ ects the 
tremendous increase in advocacy and funding seen 
during that time? Hardly. Most of the increase was due to 
reformulated or repurposed drugs already in existence. 
For disorders whose global control hinges on preventive 
chemotherapy with a limited number of resistance-
susceptible drugs, the outlook is worrying.
From a shortage of drugs to a shortage of people: the 
human resources for health crisis is once more brought 
to our attention by Giorgio Cometto and colleagues in 
their Comment. They document the daunting challenge 
of trying to improve well known deﬁ ciencies in the 
availability, productivity, and distribution of health 
workers in an ageing world under ﬁ nancial duress. 
The increased relevance to primary care in light of the 
pursuit of universal health coverage, is also picked up by 
Shabir Moosa and colleagues in their Correspondence. 
Cometto and colleagues call for a change of mindset 
and set out a bold conceptual framework for addressing 
this issue. As The Lancet Global Health went to press, the 
doors were also closing on the Third Global Forum on 
Human Resources for Health in Recife, Brazil. The meeting 
elicited national commitments to a systematic and 
forward-looking approach to workforce development and 
commitments from international partners to track oﬃ  cial 
development assistance for capacity building. Participants 
also requested WHO’s commitment to an accountability 
process to monitor progress on these promises.
Finally, onto an example of progress. Lucie Cluver and 
colleagues’ Article reveals that national child support 
grants in South Africa can have speciﬁ c beneﬁ ts beyond 
those of poverty reduction alone. Their case–control 
study found that adolescent girls whose families received 
a monthly government cash beneﬁ t were signiﬁ cantly 
less likely to engage in sex for money and sex with 
older men—both known risk factors for HIV—than were 
girls from families who did not receive the beneﬁ t. In 
their linked Comment, Stefano Bertozzi and Juan-Pablo 
Gutiérrez highlight the potential for certain poverty-
alleviation schemes to increase risk behaviours such as 
alcohol and drug taking and the purchasing of sex in 
men, and thus the importance of Cluver and colleagues’ 
study in exploring some of these unexpected eﬀ ects.
The last word goes to Chris Collins and Chris Beyrer, 
who strike a warning note to those keen to embrace the 
brave new world of country ownership of the HIV/AIDS 
response: “quick transitions could seriously undermine 
sustainability”. So, let us welcome change, but let’s 
make sure it is 100% for the better.
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